When question about the recent share price rise this was part of the reply to asx
Quote
3. As previously announced the FDA mid-cycle review process is scheduled for completion in 1Q 2023. This is considered a significant milestone event, as it will provide written feedback from FDA if there are any significant review issues remaining for product approval. The Company is waiting to receive this communication from FDA.
end of quote
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-6148
-
-
- There are more pages in this discussion • 9,110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $636.1M |
Open | High | Low | Value | Volume |
35.5¢ | 36.0¢ | 34.3¢ | $1.470M | 4.203M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 204423 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 425918 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 204423 | 0.345 |
25 | 909488 | 0.340 |
13 | 290343 | 0.335 |
12 | 315925 | 0.330 |
8 | 297013 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 425918 | 13 |
0.355 | 211219 | 11 |
0.360 | 284582 | 8 |
0.365 | 474265 | 6 |
0.370 | 218000 | 2 |
Last trade - 14.00pm 17/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online